What is new in rhabdomyosarcoma management in children? - Wikidata - awgldk - TriplyDB

What is new in rhabdomyosarcoma management in children?

What is new in rhabdomyosarcoma management in children?

http://www.wikidata.org/entity/Q38050831

about

Recent advances in understanding and managing rhabdomyosarcoma Management of pediatric head and neck rhabdomyosarcoma: A case-series of 36 patients Rhabdomyosarcoma of the head and neck in children Breast relapse after metastatic alveolar rhabdomyosarcoma: Is it an incurable entity?Nonurological malignancies in children.Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status.Pediatric sinonasal rhabdomyosarcoma: A case report.

P2860

Q27024496-BA6CF451-A4C0-4EBF-968A-3DC97A51BE4D Q30369053-7E841FC5-5A54-43A3-A760-41AB3EFDE37B Q35648994-6BD8E0CA-26B8-4BC0-8ADA-4A0FE938402E Q36861423-E5E921D0-AC1C-45A0-821E-4715199898BE Q38194126-B9DF2C54-7C49-474A-8CA9-AA2E347890EC Q38902467-3B9E2DDA-BB21-4F86-B4A8-C004163AA694 Q42151740-F4F1EEE0-8994-4432-BE7D-974C1266F4BE

P2860

What is new in rhabdomyosarcoma management in children?

http://www.wikidata.org/entity/Q38050831

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

What is new in rhabdomyosarcoma management in children?

@en

type

label

What is new in rhabdomyosarcoma management in children?

@en

prefLabel

What is new in rhabdomyosarcoma management in children?

@en

P1433

Q38050831-CBA08E93-86B9-4EB8-B202-44539266AFCF

P1476

Q38050831-5AD71DB6-3C59-40A1-A1D8-E30598449E6D

P2093

Q38050831-4776FEAF-0F27-4E71-9288-C9375F0CF4D8

Q38050831-B61E5A1D-A5BE-4BAA-B96B-57D4E7FDAB39

Q38050831-D38537F6-5A22-4540-8E3B-D5E41A7103F6

P2860

Q38050831-0880E5EF-633D-48CF-8616-AEB13D4794CA

Q38050831-121D0573-D906-4CAA-8B80-15D7A1DE7FD9

Q38050831-1262286C-FEF5-4972-AC22-D357A72EF58C

Q38050831-194F1705-86AC-4C1F-9B7D-74637BE90F5F

Q38050831-1A3B2780-69DA-4291-A6A8-07EB5C0B6F03

Q38050831-1A3BE379-EF74-4636-80D9-F5F08390A847

Q38050831-1E704815-C5F0-45D6-A9E1-3FA6E1E91AD7

Q38050831-224CBB32-346F-4D87-A88D-6726D2B2647C

Q38050831-27F441C1-22D2-415D-8802-C2CF0C45E8EC

Q38050831-293250CF-A01D-4461-83A8-CA7508A81700

P2888

Q38050831-82B0A588-147E-439B-BE1D-42C32E60AC6A

P304

Q38050831-672D8D28-D605-4CBB-B7AA-15D6F2B4EB35

P31

Q38050831-1D8EAC4F-09FA-4371-B645-2F9364FAB8FA

P356

Q38050831-9F351FC9-B355-4B77-A31F-6179EBE033D9

P433

Q38050831-60CB8795-2BD2-40F4-AE3C-30C41EC89FCA

P478

Q38050831-90DF1188-AB24-4985-AC96-42430077F6E7

P577

Q38050831-D43D6671-DB90-4DC3-B2E6-C7DA28C17C7F

P6179

Q38050831-92A5D720-34DA-46D0-96C8-DDE42597A70E

P698

Q38050831-9E3C5C04-81EB-4073-88DF-A39E1BE5B554

P356

11599440-000000000-00000

P1433

Pediatric Drugs

P1476

What is new in rhabdomyosarcoma management in children?

@en

P2093

David Walterhouse

http://www.w3.org/2001/XMLSchema#string

Jennifer Reichek

http://www.w3.org/2001/XMLSchema#string

Yasmin Gosiengfiao

http://www.w3.org/2001/XMLSchema#string

P2860

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group

Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.

Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study.

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.

The Intergroup Rhabdomyosarcoma Study-I. A final report.

Pathologic classification of rhabdomyosarcomas and correlations with molecular studies.

Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's Oncology Group.

The Intergroup Rhabdomyosarcoma Study-II.

Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study.

National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing

P2888

11599440-000000000-00000

P304

389-400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11599440-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1069132289

http://www.w3.org/2001/XMLSchema#string

P698

23050743

http://www.w3.org/2001/XMLSchema#string